Clinical trials
Observational Virus Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 6 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 8 |
| ModernaTX, Inc. | 5 |
| National Cancer Institute (NCI) | 5 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| National Institutes of Health Clinical Center (CC) | 2 |
| Abbott Molecular | 1 |
| Beckman Coulter, Inc. | 1 |
| Boston University | 1 |
| CorEvitas | 1 |
| Crucell Holland BV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Virus Diseases | 46 |
| COVID-19 | 10 |
| Coronavirus Infections | 8 |
| Hepatitis | 4 |
| Influenza, Human | 4 |
| Neoplasms | 4 |
| Respiratory Tract Infections | 4 |
| Bacterial Infections | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Adenoviridae Infections | 2 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.